Stocks · Health care · Pharmaceutical Preparations

Generate Biomedicines, Inc.

GENB
United States Fiscal year ends December CIK 0002100782
$14.34 +2.50% Close, 9 Oct 2026
Price $14.34 +24.37% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 27 Feb 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Financial statements

Nothing filed here yet

No statements have been read for GENB. They arrive with the nightly refresh; a company joins the screen the first time one is.